JSR will expand biotech manufacturing | Chemical & Engineering News
Volume 95 Issue 22 | p. 15 | Concentrates
Issue Date: May 29, 2017

JSR will expand biotech manufacturing

Department: Business
Keywords: outsourcing, biologics, mammalian cell

KBI Biopharma, a subsidiary of Japan’s JSR, will spend $30 million to expand biotech drug manufacturing capacity at two U.S. sites. In Durham, N.C., KBI will add two commercial-scale, single-use mammalian cell bioreactors to complement its clinical-scale reactors. In Boulder, Colo., it will add small-scale microbial fermentation capacity to complement larger-scale equipment. KBI also plans to open a biotech analytical services lab at JSR’s electronic materials facility in Leuven, Belgium.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment